UCSF HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER
4mNpr6
4mNpr6
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Presentations<br />
Interaction between meat and fish intake and genes involved<br />
in hormones, inflammation and energetic factors, and risk of<br />
breast cancer among Hispanic and Non-Hispanic White women:<br />
The Breast Cancer Health Disparities Study<br />
Authors*: Andre E. Kim, Juan Pablo Lewinger, Shirong Zhang, Roger K. Wolff, Laura Fejerman, Esther M. John,<br />
Gabriela Torres-Mejia, Jennifer S. Herrick, Stephanie D. Boone, Avonne E. Connor, Lisa M. Hines,<br />
Kathy B. Baumgartner, Anna Giuliano, Martha L. Slaeery, Mariana C. Stern<br />
Pres #: 799 Section: 36 Presentation Date/Time: Sunday, April 17: 1:00-5:00PM<br />
Location:<br />
Presentation Type: Poster Session<br />
Fejerman Lab Expertise: Dr. Fejerman focuses on the discovery of genetic and non-genetic factors that<br />
contribute to breast cancer risk and prognosis in Latinas. Her past work established a relationship between<br />
genetic ancestry and breast cancer risk, where higher European ancestry in U.S. and Mexican Latinas was<br />
associated with an increased risk. Her subsequent research has built upon this observation, exploring genetic<br />
variants, through admixture mapping and genome-wide association approaches, as well as the possible<br />
environmental and lifestyle related factors, and ancestry-gene interactions. Recent work explores disparities in<br />
breast cancer prognosis by genetic ancestry in Latinas and its potential causes.<br />
http://fejerman.ucsf.edu<br />
__________________________________________________________________________<br />
Combining sensitivity markers to identify triple-negative<br />
breast cancer patients most responsive to veliparib/carboplatin:<br />
results from the I-SPY 2 TRIAL<br />
Authors*: Denise M. Wolf, Christina Yau, Ashish Sanil, Larmorna Brown-Swigart, Gillian<br />
Hirst, Meredith Buxton, Melissa Paolini, Olufunmilayo Olopade, Hope Rugo, Angela De Michele,<br />
Fraser Symmans, Don Berry, Laura Esserman, Laura van ‘t Veer<br />
Pres #: 858 Section: Presentation Date/Time: Sunday, April 17: 5:35-5:50PM<br />
Location: Room 391<br />
Presentation Type: Minisymposium<br />
van ‘t Veer Lab Expertise: Dr. van ’t Veer’s research focuses on personalized medicine & advancing patient<br />
management based on knowledge of the genetic makeup of the tumor as well as the genetic makeup of the<br />
patient. Her laboratory investigates human kinases & how kinase inhibitors elicit response & resistance, which<br />
is also utilized to understand agent efficacy in the I-SPY 2 TRIAL. She is the PI of the Athena Breast Health<br />
Network, a 150,000 women cohort study evaluating new paradigms to enhance breast health. She leads the<br />
targeted genome testing of 100,000 women for 9 breast cancer susceptibility genes and a selection of ~100<br />
known susceptibility SNPs. She is one of the PIs for the NIH Big Data to Knowledge Center Translational<br />
Genomics, facilitating worldwide standardization of sharing annotated genomics data.<br />
http://cancer.ucsf.edu/people/profiles/vantveer_laura.3358<br />
*<strong>UCSF</strong> authors in bold<br />
14
Change language